{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:16:39Z","timestamp":1790748999452,"version":"4.1.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.leukres.2008.06.013","type":"journal-article","created":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T09:00:49Z","timestamp":1216717249000},"page":"e19-e22","source":"Crossref","is-referenced-by-count":11,"title":["Lenalidomide therapy in systemic mastocytosis"],"prefix":"10.1016","volume":"33","author":[{"given":"Hanneke C.","family":"Kluin-Nelemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Ferenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap J.","family":"van Doormaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"van Iperen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem G.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.06.013_bib1","series-title":"WHO Classification of tumours: tumours of haematopoietic and lymphoid tissues","first-page":"292","article-title":"Mastocytosis (Mast cell disease)","author":"Valent","year":"2001"},{"key":"10.1016\/j.leukres.2008.06.013_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2141.2003.04575.x","article-title":"Diagnosis and treatment of systemic mastocytosis: state of the art","volume":"122","author":"Valent","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.06.013_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000023829","article-title":"Synthesis of basic fibroblast growth factor by murine mast cells. Regulation by transforming growth factor beta, tumor necrosis factor alpha, and stem cell factor","volume":"115","author":"Qu","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.leukres.2008.06.013_bib4","first-page":"1271","article-title":"Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4","volume":"21","author":"Sillaber","year":"1993","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2008.06.013_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1067\/mai.2002.120524","article-title":"Levels of mast cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast cell numbers and mast cell tryptase","volume":"109","author":"Brockow","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.leukres.2008.06.013_bib6","first-page":"747a","article-title":"Effects of the tyrosine-kinase inhibitor STI571 on mutated KIT and neoplastic mast cells","volume":"96","author":"Akin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.013_bib7","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.4049\/jimmunol.147.12.4224","article-title":"IL-4 regulates c-KIT proto-oncogene product expression in human mast and myeloid progenitor cells","volume":"147","author":"Sillaber","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2008.06.013_bib8","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa061292","article-title":"Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion","volume":"355","author":"List","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608002907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608002907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T08:21:07Z","timestamp":1684484467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608002907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0145212608002907"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.06.013","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}